CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Kinser, Robin D.
von Holt, Klaus
Walk, Roger A.
Roethig, Hans J.
MetadataShow full item record
AbstractSome aromatic amines are considered to be putative bladder carcinogens. Hemoglobin (Hb) adducts of 3-aminobiphenyl (3-ABP) and 4-aminobiphenyl (4-ABP) have been used as biomarkers of exposure to aromatic amines from cigarette smoke. One of the goals of this study was to determine intra- and inter-individual variability in 3-ABP and 4-ABP Hb adducts and to explore the predictability of ABP Hb adduct levels based on caffeine phenotyping. The study was conducted in adult smokers (S, n = 65) and non-smokers (NS, n = 65). The subjects were phenotyped for CYP1A2 and NAT2 using urinary caffeine metabolites. Blood samples were collected twice within 6 weeks and adducts measured by GC/MS. The levels of 4-ABP Hb adducts were significantly (p < 0.0001) greater in S (34.5 +/- 21.06 pg/g Hb) compared to NS (6.3 +/- 3.02 pg/g Hb). The levels of 3-ABP Hb adducts were below the limit of quantification (BLOQ) in most (82%) of the NS and about 10-fold lower in S (3.6 +/- 3.29 pg/g Hb) compared to 4-ABP Hb adducts. No differences were observed in the adduct levels between weeks 1 and 6 in the smokers, suggesting that a single sample would be adequate to monitor cigarette smoke exposure. The regression model developed with CYP1A2, NAT2 phenotype and number of cigarettes smoked (NCIG) accounted for 47% of the variability in 3-ABP adducts, whereas 32% variability in 4-ABP adducts was accounted by CYP1A2 and NCIG. The ratio of 4-ABP Hb adducts in adult S:NS was approximately 5:1, whereas 3-ABP Hb adducts levels were BLOQ in some S, exhibited large interindividual variability ( approximately 91% compared to 57% for 4-ABP Hb) and poor dose response relationship. Therefore, 4-ABP Hb adduct levels may be a more useful biomarker of aminobiphenyl exposure from cigarette smoke.
CitationToxicol. Appl. Pharmacol. 2006, 213 (3):198-206
DescriptionBiomarkers of exposure & effect:: validationBiomarker: 3-ABP and 4-ABP Hb adductExposure/effect represented: tar Study type (in vitro, animals, humans): humansStudy design (if human): case-controlStudy size (if human): 65 healthy adult smokers (37 females and 28 males) and 65 healthy nonsmokers (35 females and 30 males)Mode of exposure (if in vivo) (acute, chronic, root of exposure): every day smoking for 12 monthsTissue/biological material/sample size: 10ml peripheral blood Method of analysis: ref.(Kutzer, C., Branner, B., Zwickenpflug, W., Richter, E., 1997. Simultaneous solid-phase extraction and gas chromatographic-mass spectrometric determination of hemoglobin adducts from tobacco-specific nitrosamines and aromatic amines. J. Chromatogr. Sci. 35, 1-6.) , GC-MS Sensitivity (LOD): The lower limit of quantification (LLOQ) was 0.5 pg/g Hb for both 3-ABP and 4-ABP Hb adducts with linearity demonstrable up to 500 pg/g Hb (upper limit of quantification, ULOQ).Accuracy: for 3-ABP 4.7%-7.7%, for 4-ABP is 7.3%-2.5%Interday precision: : for 4-ABP is 5%-16.4%Dose-response: Both the 3-ABP and 4-ABP Hb adducts were significantly higher ( p b 0.05) in smokers compared to non-smokersThere was a significant difference (p b 0.001) in ABP adduct levels between those subjects smoking b20 cigarettes/day (3-ABP Hb = 2.76 ± 2.47 and 4- ABP Hb = 28.30 ± 19.70 pg/g Hb; n = 39) and ?20 cigarettes/ day (3-ABP Hb = 5.56 ± 3.80 and 4-ABP Hb = 46.30 ± 18.70 pg/g Hb; n = 22).the levels of 4-ABP Hb adducts were significantly lower in females, compared to male smokers, during week 1 ( p b 0.05), but not during week 6The 4-ABP Hb adduct levels in smokers were similar between week 1 and week 6 in males but significantly lower ( p b 0.05) in females during week 1 compared to week 6. There was a significant linear correlation between 3-ABP and 4-ABP Hb adducts in smokers ( p b 0.0001, r2 = 0.62).Stability in stored sample: unprocessed samples can be stored at room 4temperature for up to 24 h, processed samples at ?20 °C for up to 12.5 days, without any significant degradation. The stability of 3-ABP and 4-ABP Hb adducts in blood was confirmed for a total of 4 freeze/thaw cycles. KEYWORDS CLASSIFICATION: Adult;Aged;Aminobiphenyl Compounds;Arylamine N-Acetyltransferase;biomarkers of exposure & effect: field studies;biomarkers of individual susceptibility: field studies;Biological Markers;Carcinogens;Cytochrome P-450 CYP1A2;Female;Hemoglobins;Humans;metabolism;Male;Middle Aged;Phenotype;Protein Binding;Smoking.
- Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
- Authors: Landi MT, Zocchetti C, Bernucci I, Kadlubar FF, Tannenbaum S, Skipper P, Bartsch H, Malaveille C, Shields P, Caporaso NE, Vineis P
- Issue date: 1996 Sep
- N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
- Authors: Probst-Hensch NM, Bell DA, Watson MA, Skipper PL, Tannenbaum SR, Chan KK, Ross RK, Yu MC
- Issue date: 2000 Jun
- Biomonitoring of smoke constituents: exposure to 4-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in nonsmokers and smokers.
- Authors: Schorp MK, Leyden DE
- Issue date: 2010 Aug
- The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure.
- Authors: Dallinga JW, Pachen DM, Wijnhoven SW, Breedijk A, van 't Veer L, Wigbout G, van Zandwijk N, Maas LM, van Agen E, Kleinjans JC, van Schooten FJ
- Issue date: 1998 Jul
- Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers.
- Authors: Yu MC, Ross RK, Chan KK, Henderson BE, Skipper PL, Tannenbaum SR, Coetzee GA
- Issue date: 1995 Dec